Meet the Jury
Senior Director of Consumer Scientific Innovation, Johnson & Johnson Innovation
Elena is the Senior Director of Consumer Scientific Innovation at Johnson & Johnson Innovation. Her main responsibilities are scouting and evaluating early stage technologies and opportunities and managing external partnerships for the strategic areas within the Consumer Sector.
Prior to this role, Elena was the Senior Director of R&D Global Topical Health Care for Johnson & Johnson Consumer & Personal Products. In this position, she was responsible for seeking innovative products and claims pipelines within the franchise and oversaw the product development program for iconic brands such as Band-Aid Adhesive Bandages, Johnson & Johnson’s Red Cross and other regional brands like Compeed, Neosporin and Bengay. Elena has grown in the Johnson & Johnson Family of Companies, previously holding roles of Senior Director R&D EMEA Topical Health, performing as the Worldwide Director Women’s Health R&D, and Manager Baby & Kids R&D EMEA for Johnson & Johnson in Germany. These positions have provided her an in-depth knowledge in Research & Development across different groups as well as launch & commercialization experience of different product categories. She has filed several patents.
Elena holds a BS and MS in Food Science & Technology from Technical University Munich, Germany.
Managing Director, Techstars London
Eamonn Carey is the Managing Director at Techstars London. He was previously MD at Techstars Connection in partnership with AB InBev in New York, and has been a long term mentor, advisor and angel investor in Europe, the Middle East, Asia and the US.
In the past, Eamonn started, succeeded and failed with several startups in Europe and the Middle East – including Farmvillain – an app which some described as the ‘South Park of Facebook’. He first started building games (as an eight year old) to impress girls in the late 1980s. His efforts were unsuccessful. His love for games lived on in spite of that fact.
Since then, he has worked with Kiip – helping them establish their footprint and offices in Europe, the Middle East and Asia.
Deputy Mayor of Paris
Since 2014, Jean-Louis Missika is a Paris councilor and Deputy Mayor of Paris, in charge of urban planning, architecture, Greater Paris projects, economic development and attractiveness. From 2008 to 2014 he served as Deputy Mayor of Paris in charge of innovation, research and higher education.
Jean-Louis Missika is a media sociologist. He holds a PhD in management, a degree in philosophy and is graduated of Sciences Po Paris. He was head of the Information and Dissemination Service of the Prime Minister Michel Rocard and director of BVA, before setting up a consulting firm. He also served as Vice President of Iliad. He has taught media sociology at Sciences Po Paris.
Jean-Louis Missika has written several books, notably on media and politics: La Folle du logis. Television in Democratic Societies, with Dominique Wolton (Gallimard, 1983), La Fin de la télévision (Le Seuil/La République des idées, 2006) and Parler pour gagner, sémiotique des discours de la campagne présidentielle de 2007, with Denis Bertrand and Alexandre Dézé
(Presses de Sciences Po, 2007).
Group Head of Data Science Neuroscience, Roche Pharmaceuticals
Lianna is Group Head of Data Science Neuroscience for Roche Pharmaceuticals. She has 18 years of experience working in the pharmaceutical industry in Real World Data and Epidemiology, International Medical Affairs, and Pharmacovigilance.
Prior to this role, she was the Global Head of Real World Evidence and Epidemiology for Lundbeck, based in Paris. She enjoys managing a talented team who use innovative approaches to analyse healthcare data and answer research questions. She is also a management and development coach in training. She has lived in 4 countries and traveled to nearly 100 countries, and currently resides in London, UK. Lianna is not representing Roche, and all opinions are her own.
Arvind M. Hundal
Business Accelerator and Investment Manager
Experienced in business development and strategy in Life Science and Healthcare. Arvind’s strengths lie in her ability to problem solve in multiple ways, by applying her cumulated knowledge and expertise to balance short term needs with long term strategic goals.
Arvind has a broad scientific foundation: Small molecules NCEs, peptides, proteins, antibodies and technology platforms in a wide range of therapy areas including; oncology, metabolic, virology, inflammation, respiratory, CNS, GI and dermatology. International experience: US, UK and the Nordics and worked has across the industry from large pharmaceutical companies, to healthcare spinouts.
She is passionate and goal oriented but equally, pragmatic and straight forward. Her diversity enables her to gain a global perspective; scientific, medical and commercial. Things Arvind is proud of include; the IPO of Zealand Pharma, setting up of Albireo the GI spin-out from AstraZeneca and the acquisition of Ziarco by Novartis.
Investor and Founder of Next Play
Charu Sharma is a startup founder & angel investor, has written 3 books, educated 1M women to start their businesses, won 5 national awards, was named a Power Woman alongside Oprah, stopped a train robbery in India when she was 9, and has been to all 7 continents.
She started her startup career at a telepsychiatry startup that got acquired and currently, she is Founder and CEO of Next Play, an advanced AI app that facilitates internal mentorship matching for company employees at scale at Gilead and Splunk to name a few.
VC, and Founding Partner, SoGal Ventures and A-Level Capital
Partner and Cofounder, humble ventures
Kayode has built companies from the ground up, worked for early stage companies raising rounds, and worked on the other side in business and corporate development for Fortune 100 enterprises sourcing startups for commercial partnerships and acquisition.
Intimately aware of the challenges that diverse founders face as they strive for growth, Kayode has been a tireless advocate for the diversity of thought and approach that founders, particularly founders from underrepresented communities(defined as founders of color, women, veterans, & LGBTQ founders), bring to every endeavor.
Kayode is based in New York, and is Cofounder of humble ventures. humble’s mission is to help underrepresented founders and founders building solutions for underrepresented communities bridge the funding gap and secure commercial partnerships.He brings deep experience in digital strategy, financial services, and media and entertainment. He holds a AB from Harvard and an MBA from USC Marshall. Advising startups is his happy place.
Partner, Advent France Biotechnology
Anne joined Advent France Biotechnology, a VC firm specialising in early-stage investments in the Life Sciences, as Partner in September 2017. She was previously Senior Associate at Sofinnova Partners (2013-2017) and has over 15 years’ experience in the Life Sciences sector, acquired as Business Development Executive at Cancer Research Technology (2007-2013), the technology transfer arm of British charity Cancer Research UK, and Senior Medicinal Chemist at Cambridge Biotechnology Ltd (2003-2007). Anne’s experience includes equity financing (seed and series A), tech transfer & scouting, business development and biotech R&D.
Anne carried out postdoctoral research at Yale University after gaining her PhD in organic chemistry from the University of Bristol. She holds a diplôme d’ingénieur from the Institut National des Sciences Appliquées de Rouen, specialising in Chemistry. She is an author on seven peer-reviewed papers and an inventor on eight patent families. As part of the investment team at Sofinnova Partners, Anne supported investments in 5 companies which have raised over $200M to date through seed, Series A & B financings and listing on EuroNext.
Founder and Managing Director, Allianz Accelerator
Sylvain is the Founder and Managing Director of the Allianz Accelerator. The Allianz Accelerator was created in 2015 and had accelerated 40 startups than raised total $170M with startups Everledger, Ledger, My Coach Sport and Vulog among others.
Before joining Allianz to create the accelerator, Sylvain was the founder of a Product Strategy and Business Development Consulting firm, and mentor of international startups programs. Sylvain successfully spearheaded key management and executive positions in the enterprise IT software market for Fortune 500 covering Strategic Alliances, Business Development, Product Marketing, Product Management, CTO and Head of Engineering. He also headed, as VP Strategy and Member of the Executive Committee, major IT trends in a Silicon Valley company. Sylvain has experience in due diligence, M&A in worldwide and multicultural contexts. Sylvain holds a BSc in Computer Science and Database Management, an MBA of Entrepreneurship from MBS, an Executive from Stanford and was part of the Berkeley Methodology of Entrepreneurship program.
Global Marketing Leader, Facebook
Tawana, a former consultant turned startup employee and entrepreneur, is now a global marketing leader at Facebook helping the top 30 Global Brand Advertisers become the best mobile marketers. In this role, she leads a global team advising CMOs, business leaders, and their agencies on how best to leverage Facebook and Instagram to drive growth of their brands.
Prior to Facebook, Tawana led e-commerce strategy in China, London and the US for Pfizer and she led brand and product teams at Intuit, LeapFrog, and Johnson & Johnson, building over 100 new products for QuickBooks, Listerine, Advil, ChapStick and LeapFrog. In addition to serving on several leadership and diversity councils, she is actively involved in the NY & Silicon Valley startup community as both an investor and board member. She holds a BA in English Literature from Rutgers University, an MA in Instructional Technology & Media from Columbia University, and an MBA from the Darden School of Business, University of Virginia. Originally from the US where she lives with her 11 year old daughter and husband, she has also lived in Spain and has done business in over 15 countries.
Founder and CEO, Matador Ventures ltd
Severine brings more than 15 years of experience in Strategic Consulting and Management roles in large Corporates with a strong focus on strategy, leadership and innovation (PWC, WPP, Gucci Group).
She has worked as a VC for Quadia, a Swiss Impact Investment Fund where she was leading the London office and investments in Food and Agtech and backed entrepreneurs in late seed, series A and Bs like Ynsect, Infarm, Food Assembly, Agriconomie, Winnow and Olio. She has invested 25 M€ in these companies at the time and some of them raised very large funding then and became category leader today.
She currently runs Matador Ventures ltd, a boutique advisory and investment company where she advises large Food Corporates on innovation, corporate venturing and deal origination. She invests in Foodtech, Agtech and Digital Health start-ups on behalf of family offices and HNWI in Europe and Israel. Her areas of interests are health and nutrition, food safety, urban farming, microbiome applications, regenerative agriculture, precision farming, robotics and automation applied to restaurants, warehouses and smart logistics.
She is very active in supporting and mentoring young people and women tech entrepreneurs, raising the diversity and funding issues as much as she can, being a Mentor with StartupBootcamp and Foodbytes, and a Juror for EIT Food and Rabobank.
Severine graduated from Sciences-Po Paris and holds a Master in PPE and Mphil in Finance (M&A).
Cofounder, We Are Jane
Founding Partner, Hoxton Ventures
Hussein is a founding partner of Hoxton Ventures, a European venture capital firm based in London. The firm was founded in November 2013 with a $40 million fund, and has made 19 investments to date, which now have a collective market capitalization of $3.7 billion. Hussein currently represents Hoxton on the boards of Babylon Health, Behavox, Darktrace, TourRadar and Yieldify, and previously served as a board observer of Deliveroo.
Hussein is also an angel investor in GoCardless, Halo Neuroscience, Popxo and Signpost. He helped Eros International (NYSE:EROS) build its digital strategy and launch ErosNow, its online video platform. Hussein has also occasionally assisted the UK government with technology policy, and appears occasionally on BBC, Bloomberg, CNN and Sky News.
Previously, Hussein was an associate at Accel Partners, where he focused on consumer internet, financial technology and software investments. He helped invest in OpenGamma, Playfish (acquired by EA) and Dapper (acquired by Yahoo). Hussein joined Accel from Microsoft Corporation where he was a platform planner, product manager and senior manager. He also helped put together Safe-View (acquired by L-3), worked at Radiance Technologies (acquired by Comcast) and Studio Verso (acquired by KPMG).
Hussein holds an MBA from London Business School, and did his undergraduate studies in Symbolic Systems at Stanford University.
Consultant, Biopharmaceutical Drug Development
Stacy is the Director of Preclinical Sciences at ProMetic. She’s an experienced Principal with a demonstrated history of working in the biotechnology industry. Stacy has a strong education professional skilled in Protein Chemistry, Life Sciences, Molecular Biology, Biotechnology, and Drug Development.
Health Tech Editor, Nuadox, and Lead Publisher, InnoNurse
Managing Partner, Lotus Blooms
Teal Dye believes that educators hold the answers for every social problem and that education comes in many forms. She completed her coursework for the Master’s of Education in Human Sexuality from Widener University, and is a sexologist, educator, and trainer. She is passionate about empowering people in their bodies and voices. As a managing partner at the sex-positive boutique, Lotus Blooms, Teal has worked with countless adults who have been failed by our don’t-have-sex education system. Teal believes that with comprehensive pleasure-focused sex education individuals can build a foundation of understanding, identifying, and advocating for their boundaries and pleasure. Teal also provides trainings for organizations and presents in higher education classrooms across the Greater DC area on a variety of topics within the sexuality realm.
Strategic Advisor, Angel Investor, Cultural Producer, Deal Lawyer
Melinda Wang is a strategic advisor to startups in the fintech, blockchain-based technology, legaltech, consumer internet, VR/AR, mediatech, SaaS and private social networking spaces, and is an active angel investor. She is part of Pipeline Angels, and a member of the steering committee for Princeton Alumni Angels. She is also the Founder and Principal of MW Projects. She was previously the Executive Director of New York Artists Equity Association, and founded Equity Gallery in 2015.
Melinda has been practicing corporate law for over 15 years. She was previously Senior Vice President at XL Group plc (NYSE: XL), where she was the lead attorney on capital markets, mergers & acquisitions, corporate finance and corporate governance matters. Melinda graduated from Princeton University and received her J.D. from the University of Pennsylvania Law School. She serves on the Board of Governors of the Princeton Association of New York City and is Chair of the Association’s Arts & Culture Committee.
Founder and CEO, Center for Intimacy Justice
Jackie is the founder and CEO of Center for Intimacy Justice, which works to create equal rules in business toward women’s sexual health and wellness companies – accelerating sexual health innovation and education.
Jackie has worked in venture capital with XSeed Capital and in women’s health impact investing with Rhia Ventures (formerly called Reproductive Health Investors Alliance) and Tara Health Foundation. In particular, she has worked on investments in sex education and in contraception technology.
Previously, Jackie founded (at age 14) and nationally expanded Everybody Dance Now! (EDN!), which uses the popularity and cultural history of hip hop dance to close opportunity gaps for low-income youth. EDN! has served more than 25,000 youth and currently teaches in 8 regions.
Jackie recently completed her MBA at Stanford Graduate School of Business and is soon completing her MPA at Harvard Kennedy School. She also holds BA with University Distinction in Public Policy from Stanford.
Venture Partner, F50, and the Founder and CEO, EVVEMI
Maria Malavenda is an innovator, serial entrepreneur and previous corporate executive. Presently she serves as a Venture Partner for F50 and the Founder, CEO of EVVEMI – a personalized data-driven engagement platform for beauty and wellness services. EVVEMI has repositioned the consumer engagement with beauty and wellness services to be driven by, and operate from personal hair information, epigenetics, personality, and preference data unique to each individual’s needs. Before founding EVVEMI, Maria catalyzed several award-winning high-growth ventures in healthcare and technology–including companies acquired by Microsoft, Bosch, and IMG. Prior, she focused her efforts on Strategy and Corporate Development as a Fortune 50 executive (Johnson & Johnson, Inc) and a”Big 4″ management consultant (Deloitte, Accenture), and immersed herself in the “AI and digital data revolution” for ZoomInfo and Monster Worldwide. In Maria’s off hours she provides her expertise as a judge and mentor to programs like Harvard iLab, TechStars, MassChallenge, Women In Tech, and NAFTE.
Investment, Innovation, and Strategy Executive
Sarah Street defies the mold of the typical insurance executive—though she enjoyed a successful tenure with XL Group, a global specialty (re)insurance company, as Chief Investment Officer then Executive Vice President, Strategy and Innovation Initiatives. She is entrepreneurial-minded and thrived in her role as Director & Investment Committee member of XL Innovate, a leading insurtech venture capital firm backing startups looking to disrupt the insurance business. After beginning her career with JP Morgan Chase & Co., Sarah moved through roles of increasing responsibility in global risk management and commodity finance. She then served as Managing Director, Leveraged and Hedge Funds group in Chase’s Investment Bank, for over ten years, during which she closely advised several CEOs and owners of leading hedge fund companies.
Throughout her time at XL, she was appointed director on several startup or early stage asset manager portfolio companies which XL funded, as well as XL’s own startup alternative capital venture. She found that she thoroughly enjoyed working with entrepreneurs as they faced complex challenges, experience that she was able to apply later in her strategy and innovation role.
In addition to being a seasoned investment professional, Sarah is an active, thrill-seeking world traveler and fitness enthusiast who is energized by adventure and new challenges—whether summiting Mt. Kilimanjaro, sailing 9,500 miles across open waters in a Round the World yacht race, or honing her photography skills in the Arctic Circle. Sarah has grown intensely curious about the opportunities to enhance the amateur and pro athlete performance and opportunities for overall wellness program driven by new and emerging technologies.
In 2015 Sarah joined the board of READ Global, a not-for-profit focused on women’s empowerment in Nepal, India and Bhutan. Sarah holds a BA and MA with honors from Oxford University. She enjoys hiking, sailing, diving, and photography.
Peter is partner at Accelerace – one of Europe’s leading accelerators and early stage investors. He is a senior leader in biotech with 20 years of experience in drug discovery and development. Peter has a passion for innovation and dedicates his time to help life science startups, build supporting infrastructure in the life science ecosystems, provide advice, and invest in promising startups.
Vanessa von Frankenberg
Senior Venture Developer, Digital Health Factory, and Cofounder and Managing Director, Go Beyond Why
Vanessa is a digital health founder, certified health coach, speaker and above all a health enthusiast. She studied General Management (B.Sc.) and Entrepreneurship & Innovation (M.Sc.) and worked in Management Consulting for more than 5 years. With a focus on the transformation and restructuring of international health care companies, Vanessa learned about the challenges of different healthcare markets. Since 2018, motivated by her desire to deeply transform the way we are looking at healthcare and wellness, Vanessa has started advising and founding companies in the healthcare sector.
Vanessa works as a Senior Venture Developer for Digital Health Factory, a company builder and investment firm focusing primarily on digital therapeutics. She is also the Co-Founder and Managing Director of Go Beyond Why, a consulting firm that helps companies leverage innovation in healthcare and beauty. Vanessa’s passion lies in female and mental health tech.
Incubator manager, ICM - Brain & Spine Institute
Julien is the iPEPS-ICM incubator manager located inside the Brain and Spine Institute on the campus of the Pitié Salpêtrière Hospital, the French largest hospital and at STATION F, Europe’s largest startup campus.
He is currently supporting the development of over 30 startups in neurosciences/neurotechnology and digital health and is involved in the creation of several academics startups . He is also a mentor/expert for several organizations (business schools, EIT Health, etc.).
Julien holds a PhD in cell biology from Institut Pasteur (Paris, Fr) and a business degree from INSEAD. He first started within the business development department at Institut Curie (Paris, Fr) where he has been in charge of growing collaborations between academia and the industry in US and Europe.
Mali M Baum
CEO & Founding Partner, WLOUNGE and Founding Partner, MAGDA GROUP
Born in Tel-Aviv, Living in Berlin. Mali has 20 years’ experience of founding companies. Started her first business in 2007 and followed
this up with a global educational toys business, in Tel Aviv, which sold products in the US, Asia and across Europe. The products won numerous awards for innovation and design. Business Angel She was nominated for the ‘Digital Female Leader Award’ for 2017 and for 2018, in money category.
Mali is a regular speaker at conferences, a mentor and jury member of startup’s competitions, lecture at universities on entrepreneurship and international business in Berlin, also has a lot of investment knowledge as a business angel and growth in startups. Business angel. Mali is instrumental in creating the business and technology ecosystem in Berlin, connecting it with the her global network from Tel Aviv, New York, Silicon Valley, EU markets and Beijing, bringing opportunities for the local startups and corporations.
Managing Director, the Helix Centre
Daniel loves mission-driven startups and making things happen. He’s Managing Director at Helix Centre, a healthcare innovation lab that translates cutting-edge research into digital products and services. Their current product roadmap is focused on clinical decision support in medication safety, dementia care, care planning and stroke rehabilitation.
Previously, Daniel ran new ventures at Participle, a pioneering social enterprise that designed and delivered solutions to society’s biggest challenges. He raised approximately £7m for two ventures. Daniel’s career began in Buenos Aires, as one of the founding Directors of HelpArgentina, an online giving marketplace that connects global donors and volunteers with social organisations in Argentina.
Head of VC and Startup Partnerships (US), Google
Jason Leder has over 20 years experience developing and launching new businesses, products, and strategic partnerships. He is currently Google’s Head of VC & Startup Partnerships (US) based in New York City. Jason works across Google to accelerate partnerships with startups’ C-Level Executives/Founders and their teams by up-leveling support, uncovering new product opportunities and generating custom partnerships.
Founder and CEO, 50inTech
When managing the Willa incubator– where she supported 450 start-ups led by women- she saw the barriers and obstacles that women may face and wanted to act to change this unfair observation : the digital revolution causes disruption in many fields, except in gender-equality. Today, worldwide, women are still under-represented and under-funded in the Tech ecosystem
Caroline Ramade started 50inTech in order to bring revolution in the global industry and empower women at scale.
She’s a woman of strong conviction and action. She doesn’t want to let the future be built by leaving 50% of the population behind. She’s convinced It is time to speed things up, move to the next level and take action. It is not a question of charity, it is a major social and economic challenge – for an example a 50/50 mix in technology would increase Europe’s GDP by €9 billion.
Thijs Cohen Tervaert
Director, INKEF Capital
Thijs Cohen Tervaert is a Director at INKEF. Thijs currently also serves on the board of ViCentra and Castor. Prior to INKEF, Thijs was a strategy consultant at the Boston Consulting Group with a focus on health care and technology. He worked on projects for pharmaceutical companies, hospitals and insurers. During a one year secondment, Thijs helped to establish the Amsterdam Health and Technology Institute in 2014. Thijs is a medical doctor and graduated at Leiden University. He has also co-authored several scientific papers.
Managing Director, Chandler Chicco Agency
Andrea Dagger is the Managing Director of Chandler Chicco Agency’s flagship New York office. With two decades of experience in healthcare communications, Andrea has in-depth knowledge of and has worked in almost all major therapeutic categories. From innovative brand campaigns to award-winning patient engagement initiatives, she also has expertise in a diverse range of communications disciplines, which she has applied over her career with client such as J&J, Genentech, Pfizer, Merck, BMS, Bayer, Eli Lilly, Novo Nordisk, Sanofi and The American Red Cross.
Venture Partner, tech VC Northzone
Justin studied Drama at the University of Manchester before embarking upon a career with the BBC, Universal Music, and United News and Media. He founded global digital agency Fortune Cookie in 1997, which he grew to $25m of revenue before selling a majority stake to WPP in 2012. Now, as a Venture Partner at tech VC Northzone and privately he is now an investor and adviser to numerous early stage tech businesses in health, education, the arts, sport and marketing.
As Deputy Chair of social learning platform FutureLearn, Justin was part of the team behind Europe’s biggest private edtech deal. For the past two years he has also been Vice Chair of Unicef UK and sits on the Advisory Board of The British Museum. He was listed in Wired’s Top 100, inducted into the Digital Hall of Fame and Business Insider called him one of the UK’s coolest VC’s which is rather nice.
Founder and CEO, Women of Wearables
Marija Butkovic is digital marketing and business consultant who has worked across a range of projects in different industry sectors, including legal, journalism, tech, IoT, wearable tech and fashion tech.
She is a founder and CEO of Women of Wearables – first global organisation aiming to support, connect and mentor women and di in wearable tech, fashion tech, health tech, IoT and VR/AR.
Marija has been featured in major tech and business publications such as Forbes, TechCrunch, The Next Web, Huffington Post and many more, and regularly appears as a public speaker and panelist on conferences, meetups and corporate events. In 2017 and 2018, Marija was selected as one of the Most Influential Women in UK tech by Computer Weekly.
She regularly writes and blogs on topics of wearable tech, fashion tech, diversity, startups and entrepreneurship. She collaborates with startup accelerators and incubators in London and worldwide on delivering help as a startup mentor and advisor and is also a STEM ambassador.
Investor and Chief Medical Officer, Bongiovi Medical & Health Technologies
Dr. Weiss received a degree in Electrical Engineering and Computer Science with honors from Princeton University. He then received his Medical degree with honors from the Mt. Sinai School of Medicine in New York, followed by internal medicine internship and residency at the Mt. Sinai Hospital in New York and fellowships in Cardiology and Cardiac Electrophysiology at the University of Maryland Hospital in Baltimore. Dr. Weiss then went into private practice for 15 years in Florida, combining patient care, research, including NIH-sponsored trials, and consultancy for top medical device companies and Wall Street firms.
Since 2004, he has concurrently served as the Chief Medical Officer and/or advisor for a number of medical device companies. In this role, he has been responsible for developing and maintaining relationships with researchers worldwide, proficiency in FDA and patent/IP issues, clinical trial protocol design and development, investor relations, etc., and has presented numerous papers and lectures internationally. He is proficient in issues related to devices and engineering for medical products and the delivery of medical care, from the perspective of the physician, the hospital, insurance/third-party payors, office flow and logistics, etc.
Global CMO and President, Nuvo Group
Debra is a growth-oriented business leader and brand builder with a broad base of experience in building beloved and iconic brands at some of the world’s most admired companies in the fast-moving consumer goods and healthcare industries. In 2018, she moved to a Health Tech Start up to leverage her collective industry experience and personal passion to build something meaningful for the next generation of parents and babies.
Debra is currently Global CMO and President of the United States at Nuvo Group, an emerging leader in maternal fetal connected health. In this capacity, she is building the Nuvo global brand platform and assets and is preparing the U.S. for a lead market launch. Nuvo has a bold ambition to reinvent Pregnancy Care for the 21st century and give every life a better beginning
Before joining the Nuvo Group, Debra was President, Global Marketing Services at Johnson & Johnson (J&J) Consumer Companies. She was responsible for leading a team of 200+ and accelerating profitable growth behind J&J’s $14B portfolio of global and regional brands through the development of world-class capabilities and transformational marketing initiatives. Her key focus was fusing classical discipline with personalized marketing, advanced analytics, and external “power partnerships” to deliver hyper-relevant brand experiences.
Debra is active industry speaker and has spoken at Cannes Lion’s Health, Modern Marketing Summit, and New York Advertising Week. She was recently recognized as one of the “Top 100 Women in FemTech” and has been nominated to Brandweek’s Women Trailblazers Council.
Founder and Director, JPS Advisory Ltd
James has significant experience in the life sciences sector from academia to startups and large corporates. This experience has seen James gain unrivalled knowledge in the life science space through his work with world leading centres for innovation such as the Francis Crick Institute and the Imperial Incubator. James is now the Head of Life Science at Cushman & Wakefield, supporting organisations around the world to build new health and life science innovation spaces.
James was previously the Head of Venture Mentoring at Imperial College London (9th best University in the World) where he supported the next generation of innovators and entrepreneurs and worked with almost 200 deeptech startups. James managed a portfolio of Imperial companies who raised in excess of £100m in funding in 2017-18, created over 300 jobs. Whilst at Imperial James was pivotal in the development, launch and success of the renowned Imperial White City Incubator where he was responsible for setting up the new incubator, creating its first accelerator programme and designing and launching the UK’s first co-working laboratories for SME’s.
Prior to this, James was the Research Engagement Manager for the Francis Crick Institute and has worked for a startup in the bioscience field and as an analyst in the medical technology sector. James has an honours degree in Pharmacology & Molecular Genetics from King’s College London.